Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study
- Conditions
- Malignant Melanoma of Skin Stage IVMalignant Melanoma of Skin Stage III
- First Posted Date
- 2013-10-31
- Last Posted Date
- 2025-01-09
- Target Recruit Count
- 34
- Registration Number
- NCT01973322
- Locations
- 🇮🇹
UO Immunoterapia e laboratorio TCS, IRST IRCCS, Meldola, FC, Italy
Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients
- Conditions
- Colorectal Cancer Metastatic
- First Posted Date
- 2013-07-29
- Last Posted Date
- 2015-06-19
- Target Recruit Count
- 18
- Registration Number
- NCT01909830
- Locations
- 🇮🇹
UO Oncologia Medica IRCCS IRST, Meldola (FC), FC, Italy
Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients
- Conditions
- Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Interventions
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2016-01-01
- Target Recruit Count
- 126
- Registration Number
- NCT01885013
- Locations
- 🇮🇹
Ospedale Umberto I, Lugo, RA, Italy
🇮🇹P.O. "SS. Annunziata", Chieti, Italy
🇮🇹Centro di Riferimento Oncologico CRO, Aviano, Italy
Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2
- Conditions
- Metastatic Renal Cell CancerMalignant Melanoma, Metastatic
- Interventions
- Other: Boost of radiotherapy + high dose IL-2 treatment
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2025-01-13
- Target Recruit Count
- 46
- Registration Number
- NCT01884961
- Locations
- 🇮🇹
UO Oncologia Medica, IRCCS IRST, Meldola (FC), FC, Italy
Sequential Treatment Strategy for Metastatic Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- First Posted Date
- 2013-06-17
- Last Posted Date
- 2025-01-31
- Target Recruit Count
- 376
- Registration Number
- NCT01878422
- Locations
- 🇮🇹
Ospedale Ramazzini - ASL Modena, Carpi, MO, Italy
🇮🇹Ospedale Buffalini - ASL Cesena, Cesena, FC, Italy
🇮🇹P.O. San lazzaro, Alba, CN, Italy
Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer
- Conditions
- Gastric CancerLocally Advanced Malignant Neoplasm
- Interventions
- Other: DOX 4 cycles - SurgeryOther: DOX 2 cycles - Surgery - DOX 2 cycles
- First Posted Date
- 2013-06-13
- Last Posted Date
- 2025-01-09
- Target Recruit Count
- 106
- Registration Number
- NCT01876927
- Locations
- 🇮🇹
Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - GM Lancisi, Ancona, AN, Italy
🇮🇹USL 8 Arezzo - Presidio Ospedaliero Zona Casentino - Ospedale di Bibbiena, Bibbiena, AR, Italy
🇮🇹USL 8 Arezzo - Ospedale "Santa Maria alla Gruccia", Montevarchi, AR, Italy
Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC
- First Posted Date
- 2013-05-07
- Last Posted Date
- 2018-11-09
- Target Recruit Count
- 120
- Registration Number
- NCT01848613
- Locations
- 🇮🇹
Irccs Irst, Meldola (FC), FC, Italy
🇮🇹U.O. Oncologia Ospedale Civile Umberto I, Lugo, RA, Italy
🇮🇹U.O. Oncologia Ospedale Civile degli Infermi, Faenza, RA, Italy
Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)
- Conditions
- Breast Cancer
- First Posted Date
- 2009-12-14
- Last Posted Date
- 2013-08-02
- Target Recruit Count
- 800
- Registration Number
- NCT01031030